Table 1 Treatment plan characteristics
From: Measuring out-of-field dose to the hippocampus in common radiotherapy indications
Treatment plan | Beams | Segments | Dose per fraction [mGy] | Number of fractions | Total dose [Gy] | |
|---|---|---|---|---|---|---|
H&N (PTV + 2SIBs) | Naso I | 13 | 49 | 2120, 1800, 1640 | 33 | 69.96, 59.40, 54.12 |
Naso II | 13 | 54 | 2120, 1800, 1640 | 33 | 69.96, 59.40, 54.12 | |
Oro I | 13 | 41 | 2120, 1800, 1640 | 33 | 69.96, 59.40, 54.12 | |
Oro II | 13 | 47 | 2120, 1800, 1640 | 33 | 69.96, 59.40, 54.12 | |
Hypo I | 13 | 40 | 2120, 1800, 1640 | 33 | 69.96, 59.40, 54.12 | |
Hypo II | 13 | 44 | 2120, 1800, 1640 | 33 | 69.96, 59.40, 54.12 | |
Mamma left (PTV + SIB) | Ma large | 7 | 45 | 2140, 1800 | 28 | 59.92, 50.40 |
Ma small | 6 | 29 | 2140, 1800 | 28 | 59.92, 50.40 | |
Prostate (PTV + 2SIBs; PTV) | Prostate I | 11 | 39 | 3000, 1800, 1640 | 20 | 60.00, 36.00, 32.80 |
Prostate II | 11 | 35 | 2000 | 33 | 66.00 | |